Subcellular organelles dysfunction is implicated in various diseases, including metabolic
diseases, neurodegenerative diseases, cancer, and cardiovascular diseases. BAM15, a …

Mild uncoupling of oxidative phosphorylation is an intrinsic property of all mitochondria,
allowing for adjustments in cellular energy metabolism to maintain metabolic homeostasis …

Hyperglucagonemia has been implicated in the pathogenesis of type 2 diabetes (T2D). In
contrast to β-cells, studies on the function of the pancreatic α-cell in T2D are scarce …

Excess body fat is a risk factor for metabolic diseases and is a leading preventable cause of
morbidity and mortality worldwide. There is a strong need to find new treatments that …

Metabolic disorders such as type 2 diabetes, fatty liver disease, hyperlipidemia, and obesity
commonly co-occur but clinical treatment options do not effectively target all disorders …

Abstract Background and Aim Metabolic dysfunction‐associated steatohepatitis (MASH) is a
metabolic disorder with limited treatment options. The thyroid hormone receptor (THR)‐β …

Semaglutide is an anti-diabetes and weight loss drug that decreases food intake, slows
gastric emptying, and increases insulin secretion. Patients begin treatment with low-dose …

Metabolic disorders such as type 2 diabetes, fatty liver disease, hyperlipidemia, and obesity
commonly co-occur but clinical treatment options do not effectively target all disorders …

To evaluate the impact of jatobá-do-cerrado flour on nutritional, inflammatory, and oxidative
stress markers, an study was conducted using male Wistar rats. These animals were …

Gut microbiota is increasingly recognized as a promising target for therapeutic interventions
aimed at preventing and managing obesity and associated dysfunctions. Recently, there has …